排序方式: 共有509条查询结果,搜索用时 15 毫秒
1.
《Molecular & cellular proteomics : MCP》2022,21(12):100438
Human pancreatic stellate cells (HPSCs) are an essential stromal component and mediators of pancreatic ductal adenocarcinoma (PDAC) progression. Small extracellular vesicles (sEVs) are membrane-enclosed nanoparticles involved in cell-to-cell communications and are released from stromal cells within PDAC. A detailed comparison of sEVs from normal pancreatic stellate cells (HPaStec) and from PDAC-associated stellate cells (HPSCs) remains a gap in our current knowledge regarding stellate cells and PDAC. We hypothesized there would be differences in sEVs secretion and protein expression that might contribute to PDAC biology. To test this hypothesis, we isolated sEVs using ultracentrifugation followed by characterization by electron microscopy and Nanoparticle Tracking Analysis. We report here our initial observations. First, HPSC cells derived from PDAC tumors secrete a higher volume of sEVs when compared to normal pancreatic stellate cells (HPaStec). Although our data revealed that both normal and tumor-derived sEVs demonstrated no significant biological effect on cancer cells, we observed efficient uptake of sEVs by both normal and cancer epithelial cells. Additionally, intact membrane-associated proteins on sEVs were essential for efficient uptake. We then compared sEV proteins isolated from HPSCs and HPaStecs cells using liquid chromatography–tandem mass spectrometry. Most of the 1481 protein groups identified were shared with the exosome database, ExoCarta. Eighty-seven protein groups were differentially expressed (selected by 2-fold difference and adjusted p value ≤0.05) between HPSC and HPaStec sEVs. Of note, HPSC sEVs contained dramatically more CSE1L (chromosome segregation 1–like protein), a described marker of poor prognosis in patients with pancreatic cancer. Based on our results, we have demonstrated unique populations of sEVs originating from stromal cells with PDAC and suggest that these are significant to cancer biology. Further studies should be undertaken to gain a deeper understanding that could drive novel therapy. 相似文献
2.
Joshua Seaberg Nicholas Flynn Amanda Cai Joshua D. Ramsey 《Biotechnology and bioengineering》2020,117(8):2504-2515
Therapeutic proteins are utilized in a variety of clinical applications, but side effects and rapid in vivo clearance still present hurdles. An approach that addresses both drawbacks is protein encapsulation within in a polymeric nanoparticle, which is effective but introduces the additional challenge of destabilizing the nanoparticle shell in clinically relevant locations. This study examined the effects of crosslinking self-assembled poly(l -lysine)-grafted-poly(ethylene glycol) nanoparticles with redox-responsive 3,3′-dithiobis(sulfosuccinimidyl propionate) (DTSSP) to achieve nanoparticle destabilization in a reductive environment. The polymer-protein nanoparticles (DTSSP NPs) were formed through electrostatic self-assembly and crosslinked with DTSSP, which contains a glutathione-reducible disulfide. As glutathione is upregulated in various cancers, DTSSP NPs could display destabilization within cancer cells. A library of DTSSP NPs was formed with varying copolymer to protein (C:P) and crosslinker to protein (X:P) mass ratios and characterized by size and encapsulation efficiency. DTSSP NPs with a 7:1 C:P ratio and 2:1 X:P ratio were further characterized by stability in the presence proteases and reducing agents. DTSSP NPs fully encapsulated the model protein and displayed 81% protein release when incubated with 5 mM dithiothreitol for 12 hr. This study contributes to understanding stimulus-responsive crosslinking of polymeric nanoparticles and could be foundational to clinical administration of therapeutic proteins. 相似文献
3.
The chemiluminescence (CL) of bis(2,4,6‐trichlorophyenyl) oxalate with hydrogen peroxide in the present of cationic surfactant and gold nanoparticles was studied. The CL emission was obviously enhanced in the presence of surfactant at a suitable concentration, with a synergetic catalysis effect exhibited. Different sizes of gold nanoparticles (15 and 50 nm) showed different effects on CL intensity. Mechanisms of the CL reaction and sensitization effect are discussed. Copyright © 2008 John Wiley & Sons, Ltd. 相似文献
4.
纳米氧化锌和接种丛枝菌根真菌对大豆生长及营养吸收的影响 总被引:4,自引:0,他引:4
纳米氧化锌是应用最广的人工纳米颗粒(nanoparticles,NPs)之一,具有一定生物毒性。丛枝菌根(arbuscular mycorrhizal,AM)真菌能与陆地上80%以上的高等植物形成丛枝菌根共生体,并能改善宿主植物矿质营养,提高其抗逆性。然而纳米ZnO与丛枝菌根的关系尚不清楚。通过温室沙培盆栽试验,研究了施加不同水平纳米ZnO(0、500、1000、2000、3000 mg/kg)和接种AM真菌Acaulospora mellea对大豆生长及营养状况的影响。结果表明,3000 mg/kg的纳米ZnO显著抑制大豆植株生长,表现出植物毒性,在其他水平时没有显著影响。纳米ZnO在施加水平500、1000 mg/kg时没有抑制AM真菌对大豆根系的侵染,但是高施加水平(2000 mg/kg)时对AM真菌产生毒害,几乎完全抑制大豆根系菌根侵染。接种AM真菌仅在500 mg/kg纳米ZnO时显著促进大豆生长,增加大豆植株对P、K、N的吸收,降低根系Zn含量。纳米ZnO可能会持续释放锌离子,并抑制大豆根系对矿质营养元素的吸收,从而产生生物毒性,而AM真菌与大豆根系的共生可起到有益作用。 相似文献
5.
RNA干扰(RNA interference,RNAi)作为转录后调节机制,可靶向mRNA进行剪切降解从而发挥基因沉默效应.siRNA (small interference RNA)因其高效性和特异性而被广泛应用于药物研究中.目前,研究者们已开发了多种阳离子载体用于siRNA递送.但由于siRNA双链结构具有相对较强的刚性结构,且阴离子电荷密度较低,无法与阳离子载体形成稳定、致密的复合物,使得siRNA的应用仍面临诸多挑战,如细胞摄取率低、靶向特异性差、递送过程不稳定、潜在的细胞毒性以及易诱发免疫反应等.近年来,核酸自组装纳米结构由于其结构灵活且负电荷密度较高而受到广泛关注,有望实现siRNA药物的高效递送和基因沉默.本文综述了近年来基于核酸自组装纳米结构的siRNA递送的研究进展及其应用. 相似文献
6.
Thomas Kempa Richard A. Farrer Michael Giersig John T. Fourkas 《Plasmonics (Norwell, Mass.)》2006,1(1):45-51
A rapid, photochemical solution-phase synthesis has been developed for the production of monodisperse, nanometer-sized silver particles. The stabilizer used in the synthesis can be used to control the average diameter of the particles over a range from 1 to 7 nm. The same reaction mixture can also be employed to deposit patterns of nanoparticles with a laser via multiphoton absorption. The particles exhibit strong multiphoton absorption-induced luminescence when irradiated with 800-nm light, allowing emission from single nanoparticles to be observed readily. 相似文献
7.
Morris MC Deshayes S Heitz F Divita G 《Biology of the cell / under the auspices of the European Cell Biology Organization》2008,100(4):201-217
The recent discovery of new potent therapeutic molecules which do not reach the clinic due to poor delivery and low bioavailability have made the delivery of molecules a keystone in therapeutic development. Several technologies have been designed to improve cellular uptake of therapeutic molecules, including CPPs (cell-penetrating peptides), which represent a new and innovative concept to bypass the problem of bioavailability of drugs. CPPs constitute very promising tools and have been successfully applied for in vivo. Two CPP strategies have been described to date; the first one requires chemical linkage between the drug and the carrier for cellular drug internalization, and the second is based on the formation of stable complexes with drugs, depending on their chemical nature. The Pep and MPG families are short amphipathic peptides, which form stable nanoparticles with proteins and nucleic acids respectively. MPG- and Pep-based nanoparticles enter cells independently of the endosomal pathway and efficiently deliver cargoes, in a fully biologically active form, into a large variety of cell lines, as well as in animal models. This review focuses on the structure-function relationship of non-covalent MPG and Pep-1 strategies, and their requirement for cellular uptake of biomolecules and applications in cultured cells and animal models. 相似文献
8.
用超声驱动方法合成了CdSe/TiO_2复合纳米粒子,并通过扫描电镜(SEM)、透射电镜(TEM)、X射线衍射(XRD)、紫外可见光(UV-Vis)吸收光谱和荧光(FS)光谱对CdSe/TiO_2复合纳米粒子进行表征。使用CCK-8法测定CdSe/TiO_2对白血病细胞的可见光光催化活性并通过SEM研究HL60细胞的表面超微结构形态。实验结果表明,用CdSe/TiO_2复合纳米粒子处理的组中观察到明显的HL60细胞生长抑制,并且HL60细胞在CdSe掺杂TiO_2复合纳米粒子作用下的PDT效率显著高于TiO_2,表明可以通过CdSe的修饰有效增强TiO_2的可见光光催化活性。此外,CdSe/TiO_2在可见光辐照下在4μg/m L的终值浓度下显示非常高的光动力效率,达76%。荧光光谱分析表明,CdSe/TiO_2复合纳米粒子可能通过分离光生空穴电子对提高此复合纳米粒子的光催化活性,从而提高CdSe/TiO_2对HL60细胞的PDT灭活效率。 相似文献
9.
光声治疗是一种利用纳米材料的光声效应选择性破坏癌细胞的方法。本研究采用叶酸作为肿瘤靶向分子,以聚乙二醇包裹吲哚菁绿形成纳米粒子(ICG-PL-PEG-FA),利用此纳米粒子在近红外区的光吸收特性,开展光声治疗研究。实验结果表明,这种叶酸标记的纳米探针对高表达叶酸的EMT6细胞具有高靶向选择性和靶向光杀伤性。这种基于包含吲哚菁绿纳米探针的光声治疗将有潜力发展为一种安全,高效的癌症治疗技术。 相似文献
10.
Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector 总被引:6,自引:0,他引:6
Morishita N Nakagami H Morishita R Takeda S Mishima F Terazono B Nishijima S Kaneda Y Tanaka N 《Biochemical and biophysical research communications》2005,334(4):1121-1126
To enter the realm of human gene therapy, a novel drug delivery system is required for efficient delivery of small molecules with high safety for clinical usage. We have developed a unique vector "HVJ-E (hemagglutinating virus of Japan-envelope)" that can rapidly transfer plasmid DNA, oligonucleotide, and protein into cells by cell-fusion. In this study, we associated HVJ-E with magnetic nanoparticles, which can potentially enhance its transfection efficiency in the presence of a magnetic force. Magnetic nanoparticles, such as maghemite, with an average size of 29 nm, can be regulated by a magnetic force and basically consist of oxidized Fe which is commonly used as a supplement for the treatment of anemia. A mixture of magnetite particles with protamine sulfate, which gives a cationic surface charge on the maghemite particles, significantly enhanced the transfection efficiency in an in vitro cell culture system based on HVJ-E technology, resulting in a reduction in the required titer of HVJ. Addition of magnetic nanoparticles would enhance the association of HVJ-E with the cell membrane with a magnetic force. However, maghemite particles surface-coated with heparin, but not protamine sulfate, enhanced the transfection efficiency in the analysis of direct injection into the mouse liver in an in vivo model. The size and surface chemistry of magnetic particles could be tailored accordingly to meet specific demands of physical and biological characteristics. Overall, magnetic nanoparticles with different surface modifications can enhance HVJ-E-based gene transfer by modification of the size or charge, which could potentially help to overcome fundamental limitations to gene therapy in vivo. 相似文献